OncoTherapy Science, Inc.

Direct answer

OncoTherapy Science, Inc. is publicly traded on JPX under the ticker 4564.T.

OncoTherapy Science, Inc. is a Japanese biotechnology firm dedicated to the discovery and advancement of innovative cancer treatments. Established in 2001 and headquartered in Kawasaki, Japan, the company's robust pipeline spans various therapeutic modalities. Among its small-molecule compounds, OTS167, an inhibitor of maternal embryonic leucine zipper kinase, is undergoing Phase I/II clinical trials for acute...

Can you invest in OncoTherapy Science, Inc.?

Yes. OncoTherapy Science, Inc. trades publicly on JPX as 4564.T.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for OncoTherapy Science, Inc.

Detailed equity research is provided by MarketSnap.